Evidence map›Paper›PMID 42472062›Full record

ArticleCase reports in hematology2026

An Unusual Presentation of Philadelphia Chromosome Positive B-Cell Acute Lymphoblastic Leukemia With Isolated Osteolytic Lesions at Diagnosis: A Case Report.

Tiantian Zhang, Omer Jamy, Sravanti Rangaraju

Abstract read
In one paragraph

Article in Case reports in hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tiantian ZhangDepartment of Internal Medicine, University of Central Florida/HCA, Pensacola, Florida, USA.ORCID https://orcid.org/0009-0009-6110-1773
Omer JamyDepartment of Medicine, Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA, uab.edu.ORCID https://orcid.org/0000-0003-2411-4742
Sravanti RangarajuDepartment of Medicine, Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA, uab.edu.ORCID https://orcid.org/0000-0003-3545-0661

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia (Ph + B-ALL) is a high-risk subtype of ALL characterized by the presence of the BCR-ABL1 fusion gene and typically presents with diffuse bone marrow involvement, circulating blasts, and systemic symptoms. While extramedullary disease may occur, it is rarely the dominant or sole feature at diagnosis. Isolated skeletal involvement with a normal bone marrow evaluation is exceedingly rare and diagnostically challenging. Case Presentation: We report the case of a 56-year-old Caucasian female who presented with progressive left hip pain and extensive lytic skeletal lesions, initially raising concern for multiple myeloma or metastatic cancer. Imaging revealed multifocal FDG-avid lesions in the skeleton without evidence of a systemic disease. Bone biopsy confirmed precursor B-lymphoblastic leukemia with expression of CD45, CD34, CD79a, TdT, and CD99, and eventually detection of BCR::ABL1 p190 transcript, consistent with Ph + B-ALL. Surprisingly, bone marrow aspirate and biopsy showed normocellular trilineage hematopoiesis without morphologic or immunophenotypic evidence of leukemia. The patient was treated with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with high dose methotrexate and cytarabine (HyperCVAD/MA) plus dasatinib followed by allogeneic stem cell transplantation, achieving complete molecular and metabolic remission. Conclusion: This case highlights an atypical presentation of Ph + B-ALL with isolated extramedullary skeletal involvement and a normal bone marrow at diagnosis. Such presentations, although rare, underscore the importance of maintaining a broad differential diagnosis in patients with unexplained lytic bone lesions and unremarkable hematologic findings. Early biopsy and appropriate molecular testing of affected tissue are essential for timely diagnosis and initiation of appropriate targeted therapy.

Indexed as

acute lymphoblastic leukemia (ALL)bone marrowosteolytic lesionPh+ B-ALLtyrosine kinase inhibitors

Identifiers

PMID42472062
PMCPMC13379309

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.